AVE (AVE) News
Follow AVE (AVE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Aventis Energy Announces Effective Date of Share Consolidation
VANCOUVER, British Columbia, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to announce that further to its news release dated September
NEWS | Sep 29, 2026, 09:01 PM UTC
L
Aventis Energy Inc. (AVE) Approves 10-for-1 Share Consolidation
Aventis Energy approved a 10-for-1 consolidation, cutting outstanding shares from 94,248,477 to about 9,424,844. Effective date and new CUSIP/ISIN will be announced after CSE filings.Material DetailsContext by AI Analyst
EQUITY | Sep 23, 2026, 11:34 AM UTC
L
Aventis Energy Announces Share Consolidation
VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to announce that its board of directors has approved a conso
EQUITY | Sep 23, 2026, 11:33 AM UTC
L
Avecho Biotechnology restarts final recruitment stage for insomnia trial
Avecho Biotechnology has restarted the final recruitment stage for its key insomnia trial.
EQUITY | Aug 31, 2026, 04:06 AM UTC